Bladder Cancer
Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer.
April 19, 2024
Clinical variables associated with major adverse cardiac events following radical cystectomy.
April 19, 2024
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancer.
April 18, 2024
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
April 17, 2024
Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC): A Randomized Clinical Trial.
April 17, 2024
Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management.
April 15, 2024
Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine.
April 12, 2024
Predictors of persistent opioid use in bladder cancer patients undergoing radical cystectomy: A SEER-Medicare analysis.
April 11, 2024